---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

CEPI

🌎 cepi.net

CEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership established in 2017 to accelerate the development of vaccines against future epidemics. It focuses on developing vaccines for various pathogens, including Ebola, Lassa virus, and COVID-19, and aims to compress vaccine development timelines to 100 days. CEPI also invests in platform technologies for rapid vaccine development and ensures fair allocation of vaccines worldwide through initiatives like COVAX.

---

CEPI - Latest News and Updates

• In 2024, CEPI expanded its manufacturing network to India and Brazil and initiated Phase 2 clinical trials for a Lassa fever vaccine.
• CEPI's CEO, Dr. Richard Hatchett, announced a new collaboration to enhance regional health security and ensure affordable doses for local populations.
• CEPI is currently hiring for the position of Senior Information Technology Architect in Norway.
• CEPI launched 'The Viral Most Wanted Series' to educate about viral families and their pandemic risks.
• Nicole Lurie, executive director at CEPI, expressed concern over the lack of epidemiologic data and surveillance regarding the bird flu outbreak.

• Dr. Rebecca Farkas from CEPI will present at the 20th Annual Non-Dilutive Funding Summit on January 15, 2025, in San Francisco.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.